Cipta Sarana Medika Tbk. vs Erajaya Swasembada Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 14.05M 24h volume), while Erajaya Swasembada Tbk. trades at Rp456 (market cap 7.27T, 91.25M 24h volume). The key difference: Erajaya Swasembada Tbk. is far larger — about 45.2× Cipta Sarana Medika Tbk.'s market cap, and Erajaya Swasembada Tbk. is more actively traded (91.25M versus 14.05M). Which is the better fit depends on your goals.
| DKHH | ERAA | |
|---|---|---|
Market Cap | 160.67B | 7.27T |
Volume | 14.05M | 91.25M |
Lot | 140.49K | 912.49K |
Turnover | 899.67M | 42.38B |
Average Price | 64.04 | 464.46 |
Value | 899.67M | 42.38B |
Indicative Equilibrium Price | 64 | 456 |
Indicative Equilibrium Volume | 100 | 26K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Erajaya Swasembada Tbk (the Company) was established in Jakarta based on Notarial Deed No.7 of Myra Yuwono, S.H., dated October 8, 1996. Erajaya Group is the official distributor for 10 international mobile communication brands and an authorised partner for major mobile operators. Recently, the Group has launched its own mobile handset under the name of Venera. In 1996, PT Erajaya Swasembada, or Erajaya, the establishment of what we know today as the Erajaya Group, was incorporated.
Read more on ERAA →